文献速递胸部腹部CT

肺癌低剂量CT筛查项目参与者的肝脂肪变性

Hepatic steatosis in participants in a program of low-dose CT screening for lung cancer.
PubMed 文献 · Eur J Radiol · 2017-06-27

回顾性分析170例无症状肺癌低剂量CT筛查参与者的基线胸部CT,测量肝脏和脾脏CT值,发现肝脂肪变性(HS)频率为5.3%(肝CT值<40HU或肝/脾比值<0.8),男性、糖尿病、肺气肿和高BMI是显著预测因素,建议对肝CT值<40HU和/或肝/脾比值<0.8者转诊进一步评估。

要点

  • 低剂量胸部CT可机会性检出肝脂肪变性,肝CT值<40HU或肝/脾比值<0.8提示中重度脂肪肝。
  • 男性、糖尿病、肺气肿和高BMI是肝脂肪变性的显著预测因素。
  • 肝CT值<40HU和/或肝/脾比值<0.8时,建议转诊至初级保健医生或肝病专科进一步评估。

核心结论

  • 低剂量CT可在无症状筛查参与者中检出肝脂肪变性,频率与既往报道相似;肝CT值<40HU和/或肝/脾比值<0.8时建议转诊进一步评估。

研究设计与样本

  • 回顾性分析2011年8月至2016年4月间经IRB批准的研究中170例参与者的基线胸部低剂量CT扫描。

关键影像表现/征象

  • 平均肝脏CT值为57.6HU(标准差9.3),平均肝/脾比值为1.3(标准差0.3)。
  • 肝脏CT值<40HU者9例(5.3%),肝/脾比值<0.8者6例(3.5%),任一指标异常者9例(5.3%)。

诊断标准与关键数值

  • 肝脂肪变性定义为肝脏CT值<40HU和/或肝/脾比值<0.8。
  • 肝脏CT值<40HU检出9例(5.3%),肝/脾比值<0.8检出6例(3.5%),任一标准检出9例(5.3%)。

临床应用与阅片要点

  • 低剂量胸部CT阅片时可测量肝脏和脾脏CT值,计算肝/脾比值以机会性筛查肝脂肪变性。
  • 肝CT值<40HU和/或肝/脾比值<0.8时,建议转诊至初级保健医生或肝病专科进一步评估。
  • 男性、糖尿病、肺气肿和高BMI参与者肝脂肪变性风险较高。
  • 天冬氨酸氨基转移酶(p=0.0018)和丙氨酸氨基转移酶(p=0.012)与肝脏CT值呈负相关。
  • α1-抗胰蛋白酶血清水平降低可能是肺气肿和肝脂肪变性的共同因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Determine the frequency of moderate-to-severe hepatic steatosis (HS) in asymptomatic participants in a low-dose CT (LDCT) screening program for lung cancer, to identify risk factors, and develop recommendations.

METHODS: Baseline LDCT scans of the chest of 170 participants in an IRB-approved study between August 2011 and April 2016 were reviewed. Demographic variables, comorbidities, and liver function tests were documented. Hepatic and splenic attenuation values hounsfield unit (HU) were measured. Regression analyses were performed.

RESULTS: Average liver attenuation was 57.6HU (standard deviation (SD) 9.3) and average liver/spleen (L/S) ratio was 1.3 (SD 0.3). Liver attenuation was <40HU for 9 (5.3%), liver/spleen (L/S) ratio <0.8 for 6 (3.5%), and either <40HU or L/S ratio <0.8 for 9 (5.3%). Male sex (p=0.004), diabetes (p=0.0005), emphysema (p=0.03), and high BMI (p=0.0006) were significant predictors of HS. Aspartate aminotransferase (p=0.0018) and alanine aminotransferase (p=0.012) were negatively correlated with liver attenuation. Reduced serum levels of alpha-1-antitrypsin may be a common factor of emphysema and HS.

CONCLUSION: LDCT can detect HS in asymptomatic participants with frequencies similar to previous reports. If liver attenuation is below 40HU and/or L/S ratio below 0.8, further evaluation of HS to the primary care physician or liver specialist is recommended.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Chen X, Li K, Yip R, et al. Hepatic steatosis in participants in a program of low-dose CT screening for lung cancer. Eur J Radiol. 2017. PMID: 28712697. doi:10.1016/j.ejrad.2017.06.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。